IACH Focus on Leukemia 2020 | The resurgence in acute leukemia research development
Mohamad Mohty
• 25 Sep 2020
Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses the online congress this year and its focus on acute leukemia. In the last few years, there has been a resurgence in acute leukemia research due to a development in molecular biological technology, next-generation sequencing (NGS) and refinement in diagnosis. Despite the development in novel treatments, for some acute myeloid leukemia (AML) patients who relapse, allogeneic hematopoietic cell transplantation still remains the only valid option. This interview took place during the 2020 Annual Meeting of the International Academy for Clinical Hematology (IACH).
